Recce eyes US Defence grants with early data for R327 on burn wounds
Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| MXG | shine has gone | 08/10/13 | 0 | 2.6K | |||
|
|||||||
| MXG | yield in all the right places | 03/05/11 | 3 | 2.2K | |||
|
|||||||
| MXG | fiig rates mxupa as exceptional value | 11/04/10 | 73 | 24K | |||
|
|||||||
| MXG | brookfield trying to list a reit | 08/03/10 | 1 | 983 | |||
|
|||||||
| MXG | mxupa board call | 22/02/10 | 1 | 888 | |||
|
|||||||
| MXG | this hybrid is dropping fast. | 10/02/10 | 2 | 1.2K | |||
|
|||||||
| MXG | the right price?? 3 questions | 08/01/10 | 0 | 481 | |||
|
|||||||
| MXG | mxupa presso and conf call | 08/10/09 | 42 | 7.9K | |||
|
|||||||
See All Discussions
